Author: Prina, Elena; Ceccato, Adrian; Torres, Antoni
Title: New aspects in the management of pneumonia Cord-id: 38aabxh1 Document date: 2016_10_1
ID: 38aabxh1
Snippet: Despite improvements in the management of community-acquired pneumonia (CAP), morbidity and mortality are still high, especially in patients with more severe disease. Early and appropriate antibiotics remain the cornerstone in the treatment of CAP. However, two aspects seem to contribute to a worse outcome: an uncontrolled inflammatory reaction and an inadequate immune response. Adjuvant treatments, such as corticosteroids and intravenous immunoglobulins, have been proposed to counterbalance the
Document: Despite improvements in the management of community-acquired pneumonia (CAP), morbidity and mortality are still high, especially in patients with more severe disease. Early and appropriate antibiotics remain the cornerstone in the treatment of CAP. However, two aspects seem to contribute to a worse outcome: an uncontrolled inflammatory reaction and an inadequate immune response. Adjuvant treatments, such as corticosteroids and intravenous immunoglobulins, have been proposed to counterbalance these effects. The use of corticosteroids in patients with severe CAP and a strong inflammatory reaction can reduce the time to clinical stability, the risk of treatment failure, and the risk of progression to acute respiratory distress syndrome. The administration of intravenous immunoglobulins seems to reinforce the immune response to the infection in particular in patients with inadequate levels of antibodies and when an enriched IgM preparation has been used; however, more studies are needed to determinate their impact on outcome and to define the population that will receive more benefit.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and adequate oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and adjunctive treatment: 1, 2, 3, 4
- acute ards respiratory distress syndrome and adjuvant treatment: 1, 2, 3, 4
- acute ards respiratory distress syndrome and adrenal insufficiency: 1, 2, 3
- acute ards respiratory distress syndrome and long duration: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low moderate: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and low moderate dose: 1, 2
- acute ards respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and low quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute exacerbation and low moderate: 1
- acute infection and adequate oxygenation: 1, 2
- acute infection and adjunctive treatment: 1, 2, 3, 4, 5, 6
- acute infection and adjuvant treatment: 1, 2, 3, 4, 5, 6
- acute infection and adrenal insufficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and long duration: 1, 2, 3, 4
- acute infection and low moderate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute infection and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- adjunctive treatment and low moderate: 1, 2
- adjuvant treatment and long duration: 1
Co phrase search for related documents, hyperlinks ordered by date